Trump says ‘major’ tariffs coming on pharmaceuticals
BMS prevails in antitrust lawsuit over its defense of multiple myeloma blockbuster Pomalyst
Novo Nordisk outlays $1.09bn to boost GLP-1RA production in Brazil
AdvaMed continues pressure on White House to exempt devices from tariffs
*please scroll down for all the latest news *
Make it like cafepharma, but for different industries. Learn more about CompanyUnderground
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud
BMS prevails in antitrust lawsuit over its defense of multiple myeloma blockbuster Pomalyst
Novo Nordisk outlays $1.09bn to boost GLP-1RA production in Brazil
AdvaMed continues pressure on White House to exempt devices from tariffs
*please scroll down for all the latest news *
Make it like cafepharma, but for different industries. Learn more about CompanyUnderground
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud